Načítá se...

Evaluation of Glycemic Control and Cost Savings Associated With Liraglutide Dose Reduction at a Veterans Affairs Hospital

PURPOSE: As a result of a cost savings initiative, the Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas, selected liraglutide as its preferred glucagon-like peptide 1 receptor agonist for the treatment of patients with type 2 diabetes mellitus with a preferred maximum daily dose...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Fed Pract
Hlavní autoři: Imarhia, Fiona I., Malveaux, Janeca N.
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontline Medical Communications Inc. 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7592900/
https://ncbi.nlm.nih.gov/pubmed/33132682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12788/fp.0057
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!